Skip to content

Opening book details…

About this Medicine article

A Randomized Clinical Trial Evaluating the Efficacy and Safety of the Once-weekly Dipeptidyl Peptidase-4 Inhibitor Omarigliptin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy by Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S.
Publisher
Informa plc; Informa UK (Librapharm); Taylor & Francis; Informa UK Limited; Informa Healthcare (ISSN 0300-7995)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S.

Browse all works by Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S.